gms | German Medical Science

26th Annual Meeting of the German Retina Society

German Retina Society

27.09.2013, Hamburg

II. Genes and the retina – what matters?

Meeting Abstract (13rg10)

Next-generation sequencing: A new era in research and diagnostics of retinal dystrophies

Bolz HJ
[Full Text]
Meeting Abstract (13rg11)

Retinal dystrophies – fundamental aspects of gene therapy

Leroy BP
[Full Text]
Meeting Abstract (13rg12)

Methods in Genetics in inherited retinal disorders and Gene therapy trials

Zeitz C, Shamieh SE, Audo I, Sahel JA
[Full Text]
Meeting Abstract (13rg13)

Evaluation of the effects of ranibizumab (Lucentis®) therapy on the macular function in patients with wet age-related macular degeneration using multifocal-electroretinogram and microperimetry

Reinsberg M, Hilgers RD, Lüke J, Nassar K, Grisanti S, Lüdeke I, Lüke M
[Full Text]
Meeting Abstract (13rg14)

Standardized analysis of morphological OCT parameters and correlation with best-corrected visual acuity (BCVA) in antiangiogenic therapy of neovascular age-related macular degeneration (AMD)

Simader C, Waldstein S, Kundi M, Schmidt-Erfurth U
[Full Text]
Meeting Abstract (13rg15)

Choroidal neovascularisation (CNV) during anti-VEGF therapy: Changes in microperimetric visual field defects are similar to changes in optical coherence tomography (OCT) findings in most cases

Inhoffen W, Hagemann U, Feucht M, Aisenbrey S, Bartz-Schmidt KU
[Full Text]
Meeting Abstract (13rg16)

Identification of clinically relevant OCT parameters over two years of treatment in neovascular AMD

Schmidt-Erfurth U, Waldstein S, Kundi M, Simader C
[Full Text]
Meeting Abstract (13rg17)

Treatment of wAMD patients with VEGF inhibitors: Insights from the routine clinical practice in Germany – the PONS Study

Agostini H, Mueller S, Ehlken C, Bauer-Steinhusen U, Hasanbasic Z, Wilke T
[Full Text]
Meeting Abstract (13rg18)

The potential of the anti VEGF drugs cannot be used under real life conditions in Germany: Results from a 4 year follow up of 77 patients

Schrader WF, Bernhard A, Dietz C, Sommer K, Panidou E
[Full Text]
Meeting Abstract (13rg19)

“Real-Life”-Data on Treatment of Diabetic Macular Oedema with Ranibizumab: Effect on Visual Acuity, OCT Development and the Number of Retinal Microaneurysms

Gerding H, Hefner L, Timmermann M
[Full Text]